Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)

v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows for Operating Activities:    
Net loss $ (4,100,159) $ (4,064,627)
Adjustments to reconcile net loss to net cash used by operating activities:    
Non cash lease expense 41,297 10,622
Amortization of deferred R&D obligations participation agreements (407,085) 0
Employee and director equity compensations 1,068,373 1,367,389
Changes in assets and liabilities:    
Prepaid expenses (459,036) (128,661)
Accounts payable (246,495) (641,281)
Lease liabilities (17,598) (10,851)
Security deposits (29,058) 0
Advanced payments for R&D obligations - participation agreements 0 85,304
Accrued liabilities (17,616) 281,738
Net cash (used in) operating activities (4,167,377) (3,100,368)
Cash Flows from Investing Activities:    
Net cash from by investing activities 0 0
Cash Flow from Financing Activities:    
Proceeds of notes payable, other 628,600 190,500
Payments of notes payable, other (279,378) (127,000)
Proceeds from public sale of common stock and warrants 0 13,804,240
Expenses related to the public offering 0 (1,622,639)
Proceeds from sale of common stock warrants - participation agreements 0 55,697
Proceeds from sale of common stock - related party 0 50,000
Proceeds from sales of common stock 0 1,514,973
Net cash provided by financing activities 349,222 13,865,770
Increase/(Decrease) in Cash (3,818,155) 10,765,402
Cash at Beginning of Period 8,901,875 137,862
Cash at End of Period 5,083,720 10,903,264
Cash paid during the period for:    
Interest 4,853 2,056
Income Taxes $ 0 $ 0